FDA
Lamivudine; Zidovudine
The FDA lists this product in 7 strengths and forms.
Composition
- Active ingredients
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG · TabletANDA078929-001 · Tentative approval
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG · TabletNDA022296-001 · Tentative approval
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG · TabletNDA200748-001 · Tentative approval
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG · TabletThis page
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG · TabletNDA204914-001 · Tentative approval
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG; EFAVIRENZ 600MG · TabletNDA021943-001 · Tentative approval
- LAMIVUDINE 30MG; ZIDOVUDINE 60MG · Tablet, for suspensionNDA202814-001 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA201151.
At a glance
- Brand name
- Lamivudine; Zidovudine
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Cipla Limited
- Status
- Tentative approval
- FDA approval
- 22 Sept 2011
- Application
- NDA201151-001